The NeuMoDx HIV-1 assay, a polymerase chain reaction (PCR) human immunodeficiency virus (HIV) viral load test from NeuMoDx Molecular, Ann Arbor, Mich, has received a CE marking. This test completes the NeuMoDx blood-borne viral menu, which already includes tests for hepatitis B virus and hepatitis C virus viral loads.
NeuMoDx Molecular offers solutions that integrate the entire molecular diagnostic process—from extraction to detection—with the first results available in about 80 minutes for viral load tests.
Sundu Brahmasandra, PhD, NeuMoDx Molecular.
“We are extremely excited to expand our blood-borne virology test menu by adding the NeuMoDx HIV-1 assay for detection and quantitation of HIV-1 RNA on the automated NeuMoDx 96/288 Molecular systems,” says Sundu Brahmasandra, NeuMoDx president and chief operating officer. “We are committed to continued assay development to further assist laboratories and the patients they serve.”
For more information, visit NeuMoDx Molecular.
Featured image: NeuMoDx 288 Molecular system.
